Syensqo NV

Common Name

Syensqo

Country

Belgium

Sector

Basic Materials

Industry

Chemicals

Employees

13,000

Ticker

SYENS

Exchange

EURONEXT

Website

www.syensqo.com

Description

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions organization, primarily engaged in providing clinical development services. The company plays a critical role in the pharmaceu... Show more

Financial Statements of Syensqo

Below are the financial statements of Syensqo, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of EUR	2024	2023
Sales	6,846^a	7,065^a
Of which revenue from non-core activities	283^a	231^a
Of which net sales	6,563^a	6,834^a
Cost of goods sold	-4,627^a	-4,690^a
Gross profit	2,219^a	2,375^a
Commercial costs	-308^a	-296^a
Administrative costs	-697^a	-521^a
Research and development costs	-342^a	-339^a
Other operating gains and (losses)	-161^a	-141^a
Earnings from associates and joint ventures	21^a	25^a
Results from portfolio management and major restructuring	-243^a	-388^a
Results from legacy remediation and major litigations	-18^a	-168^a
EBIT	471^a	547^a
Cost of borrowings	-113^a	-190^a
Interest on loans and short term deposits	22^a	81^a
Other gains and (losses) on net indebtedness	-4^a	-31^a
Cost of discounting provisions	-18^a	-28^a
Result from equity instruments measured at fair value	-7^a	10^a
Profit/(loss) for the year before taxes	352^a	389^a
Income taxes	-357^a	-192^a
Profit/(loss) for the year	-5^a	197^a
Attributable to	—	—
Syensqo share	-5^a	193^a
Non-controlling interests	0^a	3^a
Net sales	6,563^a	6,834^a
Revenue from non-core activities	283^a	231^a
Raw materials, utilities and consumables used	-2,940^a	-2,931^a
Changes in inventories	8^a	-114^a
Personnel expenses	-1,525^a	-1,591^a
Wages and direct social benefits	-1,175^a	-1,219^a
Employer's contribution for social insurance	-270^a	-276^a
Pensions and insurance benefits	-59^a	-74^a
Other personnel expenses	-20^a	-22^a
Depreciation, amortization and impairments	-732^a	-739^a
Other variable logistics expenses	-209^a	-181^a
Other fixed expenses	-823^a	-605^a
Addition and reversal of provisions (excluding employee benefit obligations)	-92^a	-387^a
Income from cross indemnities, PFAS insurance indemnities, energy hedging novation and Edison partial award	0^a	213^a
M&A costs and gains and losses on disposals	-83^a	-208^a
Earnings from associates and joint ventures	21^a	25^a
EBIT	471^a	547^a

Verified Sources Behind Syensqo’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Syensqo’s data sources below and access millions more through our Disclosure Search.

a. Syensqo's Integrated Report 2024

Trace every data point back to Syensqo’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Syensqo NV

Financial Statements of Syensqo

Verified Sources Behind Syensqo’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Solvay SA

Kemira Oyj

PETRONAS Chemicals Group Bhd

PTT Global Chemical PCL

Methanex Corp

Resonac Holdings Corp